Abby Tyler
About Abby Tyler
Abby Tyler is the Head of Immunoassay R&D, known for leading the development of widely utilized multiplexed immunoassays and currently focusing on ovarian cancer diagnostic tests.
Abby Tyler: Head of Immunoassay R&D
Abby Tyler serves as Head of Immunoassay Research and Development (R&D), bringing extensive experience in the creation and oversight of various immunoassay platforms. Abby is recognized for her leadership in expanding the boundaries of immunoassay technology and for her role in developing innovative research products.
Education in Chemical and Biological Engineering
Abby Tyler holds degrees in Chemical and Biological Engineering from Utah State University and the University of Colorado at Boulder. Her academic background provided a strong foundation for her technical expertise and her ability to tackle complex problems in the field of immunoassay development.
Innovative Multiplexed Immunoassay Projects
Throughout her career, Abby Tyler has led several multiplexed immunoassay development projects. These projects have resulted in the creation of widely utilized research products. Her ability to manage and drive these projects forward showcases her leadership and innovative mindset.
Development of Ovarian Cancer Diagnostic Tests
In her current role, Abby Tyler is leveraging her skills to develop AOA’s ovarian cancer diagnostic tests. These efforts are a testament to her commitment to improving diagnostic accuracy and providing valuable tools for cancer research and treatment.